Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KCK Group is a multi-billion dollar single-family office based in New York that manages the assets of the Kassar family. The firm is highly active in the life sciences sector, with a dedicated division focused on medical technologies, biotechnology, and pharmaceutical innovations. KCK invests across all stages of company development, from early-stage venture capital to growth equity and public market investments. Its life sciences portfolio includes prominent companies such as RefleXion Medical, Aerami Therapeutics, and Earlens Corporation. The firm is known for its long-term investment horizon and its ability to provide significant follow-on capital to its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York-based single family office.